The Medical Letter on Drugs and Therapeutics
Miconazole (Oravig) for Oropharyngeal Candidiasis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Miconazole (Oravig) for Oropharyngeal Candidiasis
The FDA has approved a buccal tablet formulation of miconazole (Oravig – Strativa) for local treatment of oropharyngeal candidiasis in adults. Miconazole has been available for many years in topical formulations for treatment of superficial...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Miconazole (Oravig) for Oropharyngeal Candidiasis
Article code: 1352d
 Electronic, downloadable article - $45

Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.